First published · Last updated
Dual-sensitive nanocomposites based on poly(4-vinylpyridine-co-N-vinylcaprolactam) and copper oxide nanoparticles for controlled doxorubicin delivery
A 2026 journal article describes dual-sensitive nanocomposites combining a vinylpyridine–vinylcaprolactam copolymer with copper oxide nanoparticles to enable controlled delivery of the chemotherapy drug doxorubicin. The item is listed as a journal article published by Elsevier BV on 2026-10-01.
Categories: science-and-space, public-health, technology
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 2/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 1/10
Why it matters
The article presents a materials approach aimed at controlled delivery of a chemotherapy drug.

